ReviewFrontiers in immunology2026
Ferroptosis-immune crosstalk in ionizing radiation-induced testicular injury: mechanisms and therapeutic opportunities.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accumulating evidence suggests that ferroptosis-an iron-dependent, lipid peroxidation-driven form of regulated cell death-may contribute substantially to ionizing radiation (IR)-induced testicular injury. In this review, we develop a hypothesis-generating framework for ferroptosis-immune crosstalk in the testis. Within this framework, ferroptotic injury to Sertoli cells is proposed to compromise the blood-testis barrier (BTB), potentially facilitating autoantigen exposure and adaptive immune activation; reciprocal inflammatory signaling may, in turn, increase the susceptibility of neighboring cells to ferroptosis. Potential interactions between ferroptosis and apoptosis, autophagy, pyroptosis, and necroptosis are considered as additional components of this proposed network. We summarize clinically used drugs and emerging strategies targeting ferroptosis, including iron chelators, radical scavengers, NRF2 activators, natural antioxidants, and nanomedicine. Key challenges such as the temporal dynamics of ferroptosis, dose-dependent effects, and translational gaps are discussed. This framework is intended to organize current evidence, identify testable mechanistic links, and guide future studies of male fertility preservation through ferroptosis-immune modulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.